| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 12/12/2007 | CN100353962C Medicine composition for curing inflammatory bone disease and process for preparing the same |
| 12/12/2007 | CN100353957C Chinese medicinal herb composition for treating rheumatism |
| 12/11/2007 | US7307091 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 12/11/2007 | US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 12/11/2007 | US7307080 Nuclear enzyme poly(adenosine 5'-diphospho-ribose) polymerase inhibitors; protection against ill effects of reactive free radicals and nitric oxide |
| 12/11/2007 | US7306903 Use of test cells comprising DNA defining a morphogen-responsive transcription activating element operatively associated with reporter gene, increase in expression of detectable gene product after exposing test cell to candidate compound indicates ability of compound to induce morphogen-mediated effect |
| 12/11/2007 | US7306783 Complexing; drug delivery; in situ imaging; detection apoptosis |
| 12/06/2007 | WO2007139887A2 Methods for treating bone or joint inflammation |
| 12/06/2007 | WO2007139856A2 Heterobicyclic metalloprotease inhibitors |
| 12/06/2007 | WO2007139346A1 Composition for induction or inhibition of stem cell differentiation |
| 12/06/2007 | WO2007139230A1 Seven-membered ring compound, production method thereof and pharmaceutical use thereof |
| 12/06/2007 | WO2007139164A1 Humanized anti-human osteopontin antibody |
| 12/06/2007 | WO2007138998A1 Pharmaceutical composition comprising nitrogenated fused cyclic compound |
| 12/06/2007 | WO2007138994A1 Hsp90 inhibitor |
| 12/06/2007 | WO2007138961A1 Prophylactic or therapeutic agent for disorder induced by macrophage migration inhibitory factor |
| 12/06/2007 | WO2007138322A1 New use for cannabinoid |
| 12/06/2007 | WO2007138147A1 Use of phytate as agent inhibiting dissolution of crystals of calcium salts for the prevention of osteoporosis |
| 12/06/2007 | WO2007137833A1 Specifically adapted plant-derived redox catalyst and method for the production thereof |
| 12/06/2007 | WO2007137738A1 Spirocyclic nitriles as protease inhibitors |
| 12/06/2007 | WO2007137674A1 Sulphated hyaluronic acid for treating degenerative osteoarthritis |
| 12/06/2007 | WO2007044375A3 Pth formulations and methods of use |
| 12/06/2007 | WO2007042885A3 Therapeutic combination comprising methotrexate and a specified inhibitor of mek1 and mek2 |
| 12/06/2007 | US20070282100 Boronic ester and acid compounds, synthesis and uses |
| 12/06/2007 | US20070281963 tyrosine kinase inhibitors such as 3-amino-2-(2-chloro-5-hydroxyphenyl)-7-(3-morpholin-4-ylpropoxy)-2,5-dihydro-4H-pyrazolo[4,3-c]quinolin-4-one, used as anticarcinogenic or antiproliferative agents |
| 12/06/2007 | US20070281948 Substituted 2-pyridone derivatives, method for their preparation and their use as medicament |
| 12/06/2007 | US20070281939 5-(3,5-Dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(1-hydroxy-cycloheptylmethyl)benzamide derivatives in which the triazine ring has various 4-substituents, e.g., carbamoylmethyl-, dimethylaminoethyl-, acetylaminoethyl-, and pyridinylmethyl-; treating rheumatoid arthritis |
| 12/06/2007 | US20070281938 Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1 |
| 12/06/2007 | US20070281933 Novel Indazole Carboxamides And Their Use |
| 12/06/2007 | US20070281931 Pharmaceutical Composition Containing a P2x7 Receptor Antagonist and Methotrexate |
| 12/06/2007 | US20070281919 Aminothiazole Derivatives And Their Use As CRF Receptor Ligands |
| 12/06/2007 | US20070281915 Porphyrin Derivatives and Their Use in Photodynamic Therapy |
| 12/06/2007 | US20070281026 Elastin stabilization of connective tissue |
| 12/06/2007 | US20070281009 N-Acetylglucosamine Tablet Disintegrating In Oral Cavity And Process For Producing The Same |
| 12/06/2007 | US20070280959 Use Of Platelets Or Platelet Rich Plasma(Prp) |
| 12/06/2007 | US20070280958 homodimer-forming chemokines such as Chemokine (C-C motif) ligand 2 (CCL2) having a single amino acid substitution in the dimerization interface that alters the pattern of hydrogen bonds; for inflammatory, autoimmune, or infectious diseases |
| 12/06/2007 | US20070280952 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders |
| 12/06/2007 | US20070280946 Antibody to 5' -Deoxy-5' - Methylthioadenosine And Uses Thereof |
| 12/06/2007 | US20070280886 Diagnostics and Therapeutics for Diseases Associated with Adrenomedullin Receptor (Amdr) |
| 12/06/2007 | CA2654281A1 Use of phytate as agent inhibiting dissolution of crystals of calcium salts for the prevention of osteoporosis |
| 12/06/2007 | CA2653835A1 New use for cannabinoid |
| 12/06/2007 | CA2653667A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 12/06/2007 | CA2653662A1 Spirocyclic nitriles as protease inhibitors |
| 12/06/2007 | CA2653661A1 Humanized anti-human osteopontin antibody |
| 12/06/2007 | CA2653660A1 Sulphated hyaluronic acid for treating degenerative osteoarthritis |
| 12/06/2007 | CA2653319A1 Hsp90 inhibitor |
| 12/06/2007 | CA2653131A1 Heterobicyclic metalloprotease inhibitors |
| 12/06/2007 | CA2652044A1 Pyrrolopyrimidine compounds and their uses |
| 12/05/2007 | EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1862451A1 Adamantane derivatives for the treatment of inflammatory diseases |
| 12/05/2007 | EP1862450A2 Novel compounds |
| 12/05/2007 | EP1862170A1 Protein formulation |
| 12/05/2007 | EP1862165A2 Prevention and treatment of androgen-deprivation induced hot flashes |
| 12/05/2007 | EP1861403A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 12/05/2007 | EP1861400A1 Crystal forms of an imidazole derivative |
| 12/05/2007 | EP1861389A1 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof |
| 12/05/2007 | EP1861372A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 12/05/2007 | EP1861100A1 3 , llB-CIS-DIHYDROTETRABENAZINE FOR THE TREATMENT OF A PROLIFERATIVE DISEASE OR AN INFLAMMATION |
| 12/05/2007 | EP1861072A2 Nanocells for diagnosis and treatment of diseases and disorders |
| 12/05/2007 | EP1638544B1 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 12/05/2007 | EP1404324B1 Prodrugs of gaba analogs, compositions and uses thereof |
| 12/05/2007 | EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1368318B1 Calcilytic compounds |
| 12/05/2007 | EP1202705B1 Composition for treating dentin hypersensitivity |
| 12/05/2007 | EP1173252B1 Products for brachytherapy and methods for their production |
| 12/05/2007 | CN101083989A Use of thiazolidinone derivatives as antiangiogenic agents |
| 12/05/2007 | CN101081296A Method for preparing b type haemophilus influenzae capsular polysaccharide and united vaccines thereof |
| 12/05/2007 | CN101081290A Chinese medicinal material preparation for relieving pain |
| 12/05/2007 | CN101081275A Natural Chinese medicinal materials decoction tea preparation for preventing and treating mastoid gristle rehab upgrowth slowness disease |
| 12/05/2007 | CN101081265A Chinese medicinal materials for treating many kinds of bone fracture disease effectively |
| 12/05/2007 | CN101081254A Notoginseng vulnerary extract and method for making same and application |
| 12/05/2007 | CN101081199A Face nursing cream |
| 12/05/2007 | CN101081196A Environmental protection type face-cleaning articles |
| 12/05/2007 | CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/05/2007 | CN100352921C Compositions and methods for identifying antigens which elicit an immune response |
| 12/05/2007 | CN100352844C Recombinant anti-osteopontin antibody and use thereof |
| 12/05/2007 | CN100352840C Nucleus factor-kB p50 subunit combination peptide, preparation and application thereof |
| 12/05/2007 | CN100352807C Chemical compounds |
| 12/05/2007 | CN100352804C 酰胺衍生物 Amide derivatives |
| 12/05/2007 | CN100352510C Therapeutically useful triethyleneglycol cholesteryl oligonucleotides |
| 12/05/2007 | CN100352496C Lugua polypeptides for injection and its preparing process |
| 12/05/2007 | CN100352494C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 12/05/2007 | CN100352493C Method of treating tumors |
| 12/05/2007 | CN100352489C Dog bone contained composition for treating rheumatoid arthritis |
| 12/05/2007 | CN100352464C A medicine for treating osteoporosis |
| 12/05/2007 | CN100352444C A process for the preparation of piroxicam: beta-cyclodextrin inclusion compounds |
| 12/04/2007 | US7304174 CaSR antagonist |
| 12/04/2007 | US7304166 (2S,4S)-2-Cyano-4-fluoro-1-[(2-hydroxy-1,1-dimethyl)ethylamino]acetylpyrrolidine benzenesulfonate; dipeptidyl peptidase IV inhibitors with high-purity uniform crystal form and excellent solid-state stability |
| 12/04/2007 | US7304091 Statin-like compounds |
| 12/04/2007 | US7304083 2-iminoimidazole derivatives (2) |
| 12/04/2007 | US7304082 5-Anilino- or phenylalkylamino-3-furanylalkyl-4H-1,2,4-triazoles (ethyl 5-(5-phenylamino-4H-[1,2,4]triazol-3-ylsulfanylmethyl)-furan-2-carboxylate); type 2 methionine aminopeptidase inhibitors; antiproliferative agents |
| 12/04/2007 | US7304071 stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant; 2-amino-4-(p-aminocarbonyl)phenyl-substituted pyrimidine compounds |
| 12/04/2007 | US7304066 Pyridyl cyanoguanidine compounds |
| 12/04/2007 | US7304035 Stimulation of bone growth with thrombin peptide derivatives |
| 12/04/2007 | US7304033 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 12/04/2007 | US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein |
| 12/04/2007 | CA2337800C Farnesyl protein transferase inhibitors for treating arthropathies |
| 12/04/2007 | CA2157506C Osteogenic growth oligopeptides and pharmaceutical compositions containing them |
| 11/29/2007 | WO2007135781A1 Peptide capable of enhancing the activity of ephrin-b2, salt thereof, composition for medical purposes, kit for therapy |
| 11/29/2007 | WO2007135505A2 Veterinary pharmaceutical compositions for the treatment of pain and inflammation |
| 11/29/2007 | WO2007135294A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |